CLDX logo

Celldex Therapeutics (CLDX) Interest expense

annual interest expense:

N/A
December 31, 2024

Summary

  • CLDX annual interest expense is not available.

Performance

CLDX Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCLDXincome statement metrics

quarterly interest expense:

N/A
March 31, 2025

Summary

  • CLDX quarterly interest expense is not available.

Performance

CLDX quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCLDXincome statement metrics

TTM interest expense:

N/A
March 31, 2025

Summary

  • CLDX TTM interest expense is not available.

Performance

CLDX TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCLDXincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

CLDX Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CLDX Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

CLDX Interest expense History

DateAnnualQuarterlyTTM
Dec 2013
$927.00K(-41.2%)
$85.00K(+553.8%)
$927.00K(-22.3%)
Sep 2013
-
$13.00K(-97.5%)
$1.19M(-23.6%)
Jun 2013
-
$519.00K(+67.4%)
$1.56M(+7.4%)
Mar 2013
-
$310.00K(-11.7%)
$1.45M(-7.8%)
Dec 2012
$1.58M(-12.2%)
$351.00K(-7.9%)
$1.58M(-5.2%)
Sep 2012
-
$381.00K(-7.3%)
$1.66M(-3.3%)
Jun 2012
-
$411.00K(-5.1%)
$1.72M(-1.3%)
Mar 2012
-
$433.00K(-1.1%)
$1.74M(-2.9%)
Dec 2011
$1.80M
$438.00K(0.0%)
$1.79M(+6.1%)
Sep 2011
-
$438.00K(+0.9%)
$1.69M(+6.7%)
DateAnnualQuarterlyTTM
Jun 2011
-
$434.00K(-10.5%)
$1.59M(+6.7%)
Mar 2011
-
$485.00K(+44.8%)
$1.49M(+11.1%)
Dec 2010
$1.34M(+195.8%)
$335.00K(+0.9%)
$1.34M(-0.3%)
Sep 2010
-
$332.00K(-0.6%)
$1.34M(+28.4%)
Jun 2010
-
$334.00K(-0.9%)
$1.04M(+39.7%)
Mar 2010
-
$337.00K(-0.6%)
$748.00K(+65.9%)
Dec 2009
$452.00K(+189.7%)
$339.00K(+868.6%)
$451.00K(+302.7%)
Sep 2009
-
$35.00K(-5.4%)
$112.00K(+45.5%)
Jun 2009
-
$37.00K(-7.5%)
$77.00K(+92.5%)
Mar 2009
-
$40.00K
$40.00K
Dec 2008
$156.00K
-
-

FAQ

  • What is the all time high annual interest expense for Celldex Therapeutics?
  • What is the all time high quarterly interest expense for Celldex Therapeutics?
  • What is the all time high TTM interest expense for Celldex Therapeutics?

What is the all time high annual interest expense for Celldex Therapeutics?

Celldex Therapeutics all-time high annual interest expense is $1.80M

What is the all time high quarterly interest expense for Celldex Therapeutics?

Celldex Therapeutics all-time high quarterly interest expense is $519.00K

What is the all time high TTM interest expense for Celldex Therapeutics?

Celldex Therapeutics all-time high TTM interest expense is $1.79M
On this page